Recursion Pharmaceuticals: Artificial Intelligence, Real Disappointment [Seeking Alpha]
Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at 25 Weeks
Recursion Pharmaceuticals (RXRX) Up 6.5% Since Last Earnings Report: Can It Continue? [Yahoo! Finance]
Lightning Round: Recursion Pharmaceuticals and NuScale Power [CNBC]
Cramer's Lightning Round: Recursion Pharmaceuticals ‘has been horrendous' [CNBC]